Medtronic issues second recall after 184 serious patient injuries

Medtronic is recalling parts of its oesophageal pH monitoring system following reports that the capsule may fail to attach or detach from the delivery device as intended. A total of 184 serious patient injuries have been reported.

By Lotta Naesenius

September 1, 2026 9:42 AM

The recall concerns the Bravo CF system, which is used to place a pH-monitoring capsule in the oesophagus. The associated Bravo CF capsule delivery device is now being recalled.

Between 1 January 2025 and 7 July 2026, Medtronic received 761 complaints involving a failure of the capsule to attach or detach, 184 of which involved a serious patient injury.

1 month free trial

Get access to all content on Life Science Nordic

No commitment or card information required

Try Life Science Nordic now

Already a subscriber? Log In

Applies to personal subscription only.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.

Yes please, I would like to receive Life Science Nordics newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Nordic Read cookie and data policy.

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}

Medtronic issues second recall after 184 serious patient injuries

Fatal immune events spur trial pauses at Novartis and BMS

Eli Lilly to acquire Merida Biosciences for up to 2.9 billion dollars

AstraZeneca combination shows promise in advanced lung cancer

Medtronic issues second recall after 184 serious patient injuries

Sweden appoints its first professor of HTA

“If we can’t import it, we want to make it ourselves”

Master Medical Device Sterilization

Pfeiffer Vacuum+Fab Solutions presenterar den nya mobila läcksökaren ASM HVM

European Authorised Representative (EAR): Your partner for EU market access and compliance

SGS webinar on IVDR & MDR certification process

ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

Rätt komponenter för säkra och tillförlitliga gasapplikationer

Why are Aurevia and RAPS collaborating on the Medtech Compliance Forum?

Osynliga läckage, tydliga vinster.

Kundunika manluckor, vi hjälper dig!

EVENT | As fewer and fewer new medicines reach Swedish patients – can Swedish life science...

Recent clarification in Sweden’s clinical trial legislation

ZEISS CLINIC 360 receives FDA 510k clearance